- Nachrichtendetail
-
28.06.2024 08:04:08 - dpa-AFX: *ABBVIE GETS POSITIVE CHMP OPINION FOR EPCORITAMAB FOR TREATMENT OF RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
ABBVIE | A1J84E | NYSE | 166,520 | 08.07.24 22:00:00 | -0,730 | -0,44% | 165,000 | 166,450 | 166,540 | 167,250 |
